Australia's most trusted
source of pharma news
Wednesday, 12 November 2025
Posted 11 November 2025 PM
Italian pharma Newron is taking tentative steps toward a Federal Court battle with Australian generics giant Arrotex over its Parkinson's disease drug Xadago.
The Federal Court has ordered Arrotex to hand over material and samples regarding its generic Xadago medicines to Newron and its licensee Zambon.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.